{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:36:54Z","timestamp":1759401414932},"reference-count":69,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2001,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            To construct a prototype hybrid vaccine against\n            <jats:italic>Shigella<\/jats:italic>\n            and enterotoxigenic\n            <jats:italic>Escherichia coli<\/jats:italic>\n            (ETEC), the genes encoding the production of ETEC CS2 and CS3 fimbriae were isolated and expressed in attenuated\n            <jats:italic>Shigella flexneri<\/jats:italic>\n            2a\n            <jats:italic>guaBA<\/jats:italic>\n            strain CVD 1204. The CS2\n            <jats:italic>cotA<\/jats:italic>\n            to -\n            <jats:italic>D<\/jats:italic>\n            genes, isolated from ETEC strain C91F, and the CS3\n            <jats:italic>cstA<\/jats:italic>\n            to -\n            <jats:italic>H<\/jats:italic>\n            genes, subcloned from plasmid pCS100, were cloned into \u223c15-copy-number-stabilized pGA1 behind the osmotically regulated\n            <jats:italic>ompC<\/jats:italic>\n            promoter, resulting in high expression of both fimbriae. Under nonselective in vitro growth conditions, pGA1-CS2 and pGA1-CS3 were stable in CVD 1204, exhibiting a plasmid loss of only approximately 1% per duplication. Expression of CS2 and CS3 reduced the invasiveness of\n            <jats:italic>Shigella<\/jats:italic>\n            for HeLa cells and slowed the intracellular growth rate. Guinea pigs immunized intranasally with CVD 1204(pGA1-CS2) or CVD 1204(pGA1-CS3), or with a mixture of these strains, developed secretory immunoglobulin A (IgA) in tears and serum IgG antibodies against\n            <jats:italic>Shigella<\/jats:italic>\n            lipopolysaccharide, CS2, and CS3 antigens. Moreover, the animals were protected against keratoconjunctivitis following conjunctival challenge with virulent\n            <jats:italic>S. flexneri<\/jats:italic>\n            2a strain 2457T. Animals immunized with\n            <jats:italic>Shigella<\/jats:italic>\n            expressing CS2 or CS3 developed serum antibodies that agglutinated\n            <jats:italic>Shigella<\/jats:italic>\n            as well as an ETEC strain bearing the homologous fimbriae, whereas animals immunized with combined CVD 1204(pGA1-CS2) and CVD 1204(pGA1-CS3) developed antibodies that agglutinated all three test strains. These observations support the feasibility of a multivalent vaccine against shigellosis and ETEC diarrhea consisting of multiple\n            <jats:italic>Shigella<\/jats:italic>\n            live vectors expressing relevant ETEC antigens.\n          <\/jats:p>","DOI":"10.1128\/iai.69.5.3150-3158.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:01:19Z","timestamp":1027764079000},"page":"3150-3158","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":43,"title":["Attenuated\n            <i>Shigella flexneri<\/i>\n            2a \u0394\n            <i>guaBA<\/i>\n            Strain CVD 1204 Expressing Enterotoxigenic\n            <i>Escherichia coli<\/i>\n            (ETEC) CS2 and CS3 Fimbriae as a Live Mucosal Vaccine against\n            <i>Shigella<\/i>\n            and ETEC Infection"],"prefix":"10.1128","volume":"69","author":[{"given":"Zeev","family":"Altboum","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen M.","family":"Barry","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve","family":"Losonsky","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Galen","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron M.","family":"Levine","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.7.3311-3316.1998"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/142.3.318"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/8.Supplement_2.S131"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)90719-4"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.3.963"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/158.2.372"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.10.4074-4077.1996"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)06255-1"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.7.3437-3443.1999"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0378-1097(81)90081-1","article-title":"Immunoprotection against enterotoxigenic Escherichia coli diarrhea in rabbits by peroral administration of purified colonization factor antigen I (CFA\/I)","volume":"11","author":"De la Cabada F. J.","year":"1981","unstructured":"De la Cabada F. J. Evans D. G. Evans D. J. Jr. Immunoprotection against enterotoxigenic Escherichia coli diarrhea in rabbits by peroral administration of purified colonization factor antigen I (CFA\/I).FEMS Microbiol. Lett.111981303307","journal-title":"FEMS Microbiol. Lett."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/119.3.296"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/125.1.12"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/159.6.1126"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197612302952707"},{"key":"e_1_3_2_16_2","unstructured":"Edwards\nP.\nEwing\nW.\nIdentification of Enterobacteriaceae.\n1972\nBurgess Publishing Co.\nMinneapolis Minn"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1574-6968.1988.tb02363.x","article-title":"Non-replicating whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA\/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes","volume":"47","author":"Evans D. G.","year":"1988","unstructured":"Evans D. G. Evans D. J. Jr. Opekun A. Graham D. Y. Non-replicating whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA\/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes.FEMS Microbiol. Lett.471988117125","journal-title":"FEMS Microbiol. Lett."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.19.2.727-736.1978"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(84)90091-X"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1988.tb02485.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117991"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116134"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/164.3.533"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.12.4849-4856.1995"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0966-842X(96)10068-8"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.12.6424-6433.1999"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00003-J"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.2.507-513.1997"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.171.11.6372-6374.1989"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111143252006"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1989.tb00154.x"},{"key":"e_1_3_2_32_2","first-page":"4884","article-title":"Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli Infect","volume":"68","author":"Koprowski H.","year":"2000","unstructured":"Koprowski H. II Levine M. M. Anderson R. J. Losonsky G. Pizza M. Barry E. M. Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli Infect.Immun.68200048844892","journal-title":"Immun."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)00011-B"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00102-7"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.3.1034-1039.2000"},{"key":"e_1_3_2_36_2","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff K. L.","year":"1999","unstructured":"Kotloff K. L. Winickoff J. P. Ivanoff B. Clemens J. D. Swerdlow D. L. Sansonetti P. J. Adak G. K. Levine M. M. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.Bull. W. H. O.771999651666","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_37_2","first-page":"121","article-title":"Travellers' diarrhoea: prospects for successful immunoprophylaxis","volume":"84","author":"Levine M. M.","year":"1983","unstructured":"Levine M. M. Travellers' diarrhoea: prospects for successful immunoprophylaxis.Scand. J. Gastroenterol. Suppl.841983121134","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.3.377"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91013-Z"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200010000-00003"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)90299-4"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","unstructured":"Levine\nM. M.\nBlack\nR. E.\nClements\nM. L.\nYoung\nC. R.\nCheney\nC. P.\nSchad\nP.\nCollins\nH.\nBoedeker\nE. C.\nPrevention of enterotoxigenic Escherichia coli diarrheal infection by vaccines that stimulate antiadhesion (antipili) immunity\nAttachment of organisms to the gut mucosa.\nBoedeker\nE. C.\n1984\n223\n244\nCRC Press\nBoca Raton Fla","DOI":"10.1201\/9781351069977-27"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","unstructured":"Levine\nM. M.\nGiron\nJ. A.\nNoriega\nF.\nFimbrial vaccines\nFimbriae: adhesion biogenics genetics and vaccines.\nKlemm\nP.\n1994\n255\n270\nCRC Press\nBoca Raton Fla","DOI":"10.1201\/9781003068259-19"},{"key":"e_1_3_2_44_2","unstructured":"Levine\nM. M.\nMorris\nJ. G.\nLosonsky\nG.\nBoedeker\nE.\nRowe\nB.\nFimbriae (pili) adhesins as vaccines\nProtein-carbohydrate interactions in biological systems. The molecular biology of microbial pathogenicity.\nLark\nD. L.\nNormark\nS.\nUhlin\nB. E.\nWolf-Watz\nH.\n1986\n143\n145\nAcademic Press\nLondon England"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.44.2.409-420.1984"},{"key":"e_1_3_2_46_2","unstructured":"Levine\nM. M.\nSvennerholm\nA.-M.\nEnteric vaccines: present and future\nTextbook of travel medicine and health. B. C.\nDuPont\nH. L.\nSteffen\nR.\n2000\n252\n263\nDecker\nNew York N.Y"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.21.2.174-179.1985"},{"key":"e_1_3_2_48_2","unstructured":"Lowell\nG. H.\nProteosomes for improved nasal oral or injectable vaccines\nNew generation vaccines.\nLevine\nM. M.\nWoodrow\nG. C.\nKaper\nJ. B.\nCobon\nG. S.\n1997\n193\n206\nMarcel Dekker\nNew York N.Y"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.6.2382-2386.1995"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00425443"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.8.1974-1980.1988"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197606102942401"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.5.1408"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.2.782-788.1999"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.8.3055-3061.1996"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.1.23-27.1996"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92590-X"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1996.0040"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.22.12828"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1998.01088.x"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1086\/517812"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1086\/314543"},{"key":"e_1_3_2_63_2","first-page":"367","article-title":"Experimental keratoconjunctivitis shigellosa","volume":"4","author":"Sereny B.","year":"1957","unstructured":"Sereny B. Experimental keratoconjunctivitis shigellosa.Acta Microbiol. Acad. Sci. Hung.41957367376","journal-title":"Acta Microbiol. Acad. Sci. Hung."},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2550105"},{"key":"e_1_3_2_65_2","first-page":"2081","article-title":"Two mannose-resistant hemagglutinins on enterotoxigenic Escherichia coli of serotype 06:H16 or H-isolated from traveller's and infantile diarrhea","volume":"128","author":"Smyth C. J.","year":"1982","unstructured":"Smyth C. J. Two mannose-resistant hemagglutinins on enterotoxigenic Escherichia coli of serotype 06:H16 or H-isolated from traveller's and infantile diarrhea.J. Gen. Microbiol.128198220812096","journal-title":"J. Gen. Microbiol."},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/147.3.514"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(89)90228-4"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(94)80038-2"},{"key":"e_1_3_2_69_2","first-page":"83","article-title":"Bacterial lipopolysaccharides: extraction with phenol-water and further application of procedures","volume":"5","author":"Westphal O.","year":"1965","unstructured":"Westphal O. Jann K. Bacterial lipopolysaccharides: extraction with phenol-water and further application of procedures.Methods Carbohydr. Chem.519658391","journal-title":"Methods Carbohydr. Chem."},{"key":"e_1_3_2_70_2","first-page":"124","article-title":"Epitope analysis of the CS3 fimbrial subunit of human enterotoxigenic Escherichia coli and the construction of novel CS3::ST and CS3::LT-B immunogens","volume":"98","author":"Yakhchali B.","year":"1997","unstructured":"Yakhchali B. Manning P. A. Epitope analysis of the CS3 fimbrial subunit of human enterotoxigenic Escherichia coli and the construction of novel CS3::ST and CS3::LT-B immunogens.Behring Inst. Mitt.981997124134","journal-title":"Behring Inst. Mitt."}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.5.3150-3158.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.5.3150-3158.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T02:09:27Z","timestamp":1646446167000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.69.5.3150-3158.2001"}},"subtitle":[],"editor":[{"given":"D. L.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1128\/IAI.69.5.3150-3158.2001"],"URL":"https:\/\/doi.org\/10.1128\/iai.69.5.3150-3158.2001","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]},"assertion":[{"value":"2000-10-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-02-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}